Kura Oncology’s Komzifti is approved for treating advanced cases of acute myeloid leukemia with an NPM1 mutation. A Syndax Pharmaceuticals drug is already approved in this indication, but Kura says its drug has advantages in safety and patient convenience. The post FDA Approves Kura Oncology Leukemia Drug, Teeing Up Competition With Syndax Pharma appeared first…
Alveus Therapeutics’ Phase 2-ready lead drug hits the same two targets as Amgen’s MariTide, but with the potential for a dosing advantage. The startup’s pipeline also includes molecules that could compete with drugs in development by Roche and Novo Nordisk. The post Startup Alveus Therapeutics Emerges With $160M to Shape the Future of Obesity Drugs…
On a Sunday morning in late July, Crothall housekeeper Amari Alston couldn’t open the door to a patient’s room at Novant Health Presbyterian Medical Center in Charlotte, N.C. She has visited the patient the previous day and made it a point to make an early visit to this patient. But when the door handle wouldn’t…
Starting in May of last year, HHS Secretary Kennedy and the CDC/ACIP began to make changes to the federal vaccine schedule for children, culminating in an announcement on January 5 of this year with the most wide-ranging changes to date. This policy brief tracks the number of states that have announced they are no longer…
Steve Stadum returns to lead OHSU as it seeks to merge with Legacy Health in a deal that was announced in August 2023
Omada Health is a respected health tech company but what do customers see it? A flesh and blood and an AI analysis follows. The post What Do Consumers and AI Think Of Omada Health? appeared first on MedCity News.
Changing any status quo is challenging, but maintaining the status quo of low patient literacy in healthcare is costly and detrimental to both patients and healthcare organizations. Investing in patient literacy is therefore investing in healthcare itself. The post Oncology Nurses Are Key to Patient Literacy But They Need Support appeared first on MedCity News.
Millie’s Series A round was co-led by TMV and Foreground Capital. The financing will help the company expand its offerings and footprint. The post Millie Raises $12M to Advance Maternal Healthcare appeared first on MedCity News.
Closing cancer health equity gaps requires medical breakthroughs made possible by new funding approaches. The post The Funding Model for Cancer Innovation is Broken — We Can Fix It appeared first on MedCity News.
For community hospitals, it’s a sign of the need for a different approach to patient financial communication and payment — one that meets patients where they are and protects their dignity while avoiding undue stress on the organization’s bottom line. The post Plummeting Patient Collection Rates Call for a New Approach to Hospital Payment appeared…